COVID-19 Resurgence in Asia: What You Need to Know About JN.1 Variant

A new wave of COVID-19 infections is sweeping across parts of Asia, driven primarily by the emergence of the JN.1 variant, a sublineage of the Omicron strain. Countries including Singapore, Hong Kong, China, Thailand, and India are witnessing a surge in cases, prompting health authorities to issue advisories and reinforce preventive measures.

Singapore: Weekly COVID- 19 cases rose from 11,000 in late April to over 14,000 in early May, accompanied by a slight increase in hospitalizations. India Times + 1 Business Standard + 1

Hong Kong: Reported 1,042 new cases in the week of May 10, with the percentage of respiratory samples testing COVID-positive reaching its highest in a year. www.ndtv.com

India: As of mid-May 2025, over 257 active COVID-19 cases have been reported, primarily from Kerala, Maharashtra, and Tamil Nadu. Most cases are mild, with no hospitalizations required.

JN.1 is a descendant of the Omicron BA.2.86 lineage, first identified in August 2023. It has acquired additional mutations that may enhance its transmissibility and ability to evade immunity.

Common Symptoms:

Dry cough
Loss of taste or smell
Headache
Runny or clogged nose
Fatigue
Sore throat
Fever.
Diarrhea

While most infections are mild, vulnerable populations, such as the elderly and immunocompromised, remain at higher risk. Health experts affirm that vaccination remains the most effective defense against severe illness, even with evolving variants like JN.1. We recommend booster doses tailored to current variants, especially for high-risk groups.

Recommended Precautions: